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Abstract: Oxidation of LDL plays an important role in the pathogenesis of atherosclerosis. Increased wall 
thickness precedes plaque formation and noninvasive B-mode ultrasonographic measurement of IMT is 
considered a useful marker of the development of the carotid atherosclerosis. The present study was designed to 
assess the association of oxidized low-density lipoprotein (ox-LDL) with carotid intima-media thickness (IMT) 
in hypertensive patients.  Oxidized LDL (enzyme-linked immunosorbent assay, Elisa) and carotid IMT (high-
resolution B-mode ultrasonography) were assessed in 74 patients, aged between 45 and 65 years, diagnosticated 
with arterial hypertension. We observed significantly higher plasma levels of total cholesterol (236.32 mg %), 
LDL cholesterol (166.92 mg %), triglycerides (180.79 ± 72.05mg %) and low plasma levels of HDL-cholesterol 
(33.24 ± 7.99 mg %) in all patients. We noticed higher plasma levels of ox-LDL (77.34 mg %) and carotid IMT 
was increased (1.41 ± 0.31 mm). The statistically analysis done using Pearson’s test and Student’s t – test 
indicated that there were correlations of ox-LDL with:  IMT (p < 0.05, r=0.408), total cholesterol (p <0.05, 
r=0.498), LDL-cholesterol (p < 0.05, r= 0.527), triglycerides (p <0.05, r=) and HDL-cholesterol (p< 0.05, r = -
0.442). In conclusion, higher plasma levels of ox-LDL were associated with increased carotid IMT in 
hypertensive patients. Measurement of plasma Ox-LDL and carotid IMT may represent useful markers for 
atherosclerosis and may represent potential targets for therapeutic interventions. (231) 
 
INTRODUCTION 
 
After the initial studies by Goldstein (1979) on modification of low-density lipoprotein 
(LDL) and its role in atherosclerosis, several studies have investigated the role of modified 
LDL as a biochemical risk factor for atherosclerosis (8). Of the various modified forms of 
LDL, oxidized LDL (ox-LDL) has gained a lot of interest recently (2). 
The oxidative conversion of LDL to ox-LDL is considered to be an important event in 
the biologic process that initiates and accelerates the development of the early atherosclerotic 
lesion (10). Furthermore, circulating ox-LDL has also been proposed to give additive 
informations to that provided by Global Risk Assessment Scoring (6) for assessing the risk for 
cardiovascular diseases. 
Several studies have reported on increased circulating levels of ox-LDL in relation to 
late end points of atherosclerotic process (6) and few studies have looked at the relation of ox-
LDL with subclinical atherosclerotic markers such as IMT (9). 
The development of the B-mode ultrasound technique has made it possible to 
noninvasively study the atherosclerotic process. Intima-media thickness (IMT) of the carotid 
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artery has been used as a noninvasive indicator for the atherosclerotic process in the coronary 
arteries (5). 
We investigated in our study if plasma circulating oxidized LDL was associated with 
the thickness of the common carotid intima-media in a group of 74 hypertensive patients. 
 
MATERIAL AND METHODS 
 
A number of 74 subjects (52 men and 22 women) have voluntarily completed a 
questionnaire for identification of cardiovascular risk factors, which comprised: personal data 
(age, gender), hypertension, obesity and cigarette smoking. An objective examination 
assessed systolic and diastolic arterial blood pressure. 
All patients underwent clinical and paraclinical investigations, considering 
hypertension evolutive stages, anatomical (bidimensional echography and Doppler 
ecography), morphological (carotid intima-media thickness) and functional changes (serum 
total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, oxidized LDL). 
Hypertension was defined as a systolic blood pressure of ≥140 mmHg and/or a 
diastolic blood pressure of ≥90 mmHg as mean of three measurements in at least three visits 
at 1-week intervals or receiving antihypertensive treatment in concordance with the guidelines 
for hypertension 2008. 
Exclusion criteria were systolic blood pressure of 220 mmHg or higher, ischemic heart 
disease, acute coronary syndrome, stroke, or presence of a major illness such as cancer, liver 
disease, renal insufficiency, insulin-treated diabetes and depression. 
 
Measurement of intima-media thickness 
 
Intima-media thickness (IMT) is a marker of subclinical atherosclerosis at the level of 
the carotid arteries. It was measured by high-frequency (≥ 8 MHz) ultrasound transducers in 
both carotid arteries, on the distal straight 1 cm of the common carotid arteries, the carotid 
bifurcations, and the proximal 1 cm of the internal carotid arteries. The carotid IMT is 
determined as the average of 12 measurements (both sides 6 measurements each from the near 
and far wall of each of the three segments). A value > 1.3 mm was considered abnormal. 
 
Biochemical analysis 
  
The measurement of total cholesterol, HDL-cholesterol and triglyceride levels was 
made by current biochemical method, using Reflotom. LDL cholesterol was calculated with 
Friedewald formula (3). Ox-LDL was measured by enzyme-linked immunosorbent assay 
(Elisa). 
 
Statistic analysis 
 
All the values were presented as mean ± standard deviation. The statistically analysis 
was done using Pearson’s test (for correlation) and Student’s  
t–test. p < 0,05 was considered statistically significant. All statistical analyses were performed 
using Excel Microsoft Office 2003. Pearson correlation analysis was carried out to determine 
the relation of ox-LDL with other risk variables (total cholesterol, HDL-cholesterol, LDL-
cholesterol, triglycerides) and to determine the association of ox-LDL with IMT. 
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RESULTS AND DISCUSSIONS 
 
Distribution of traditional cardiovascular risk factors and laboratory measurements of 
the study participants are shown in Table 1. 
The subjects were predominantly male and were commonly overweight. Many 
subjects reported current smoking and a history of hypertension.  
 
Table 1.  
Characteristics of the study subjects (n = 74) 
Characteristics Mean ± SD 
Age (years) 56.63 ± 11.62 
Systolic blood pressure (mm Hg)  183.92 ± 19.06 
Diastolic blood pressure (mm Hg) 98.42 ± 5.71 
Total cholesterol (mg/dl)  236.32 ± 41.96 
Triglycerides (mg/dl)  180.79 ± 72.05 
LDL cholesterol (mg/dl) 166.92 ± 38.55 
HDL cholesterol (mg/dl) 33.24 ± 7.99 
Mean carotid IMT (mm)  1.41  ± 0.31 
Ox-LDL (mg/dl) 77.34 ± 24.78 
 
The correlation between ox-LDL and total cholesterol was direct, moderate and 
significant (p <0.05, r=0.498). The correlation between ox-LDL and HDL-cholesterol was 
inverse, weak and significant (p< 0.05, r = -0.442). The correlation between ox-LDL and LDL 
was moderate, direct and significant (p < 0.05, r= 0.527). The correlation between ox-LDL 
and triglycerides was weak, direct and significant (p=0.032 and r=0.285). 
The correlation between ox-LDL and IMT was direct, weak and significant (fig. 1) 
 
 
Fig. 1. Correlation between ox-LDL and IMT 
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Arterial thickening provides the earliest evidence of atherosclerosis, or hardening of 
the arteries, the beginning stage of a disease process that leads to heart disease and stroke 
(Figure 2). 
The correlations coefficient between ox-LDL, lipid parameters and IMT were 
presented in table II.  
 
Table 2. 
 Correlations coefficient between ox-LDL, lipid parameters and IMT 
Variant r P 
CT 0.498 <0.05 
LDL-Cholesterol 0.527 <0.05 
HDLcholesterol -0.442 <0.05 
Triglycerides 0.385 0.032 
IMT 0.408 <0.05 
 
The role of ox-LDL in atherosclerosis is well recognized (10). The results of the 
present study showed that ox-LDL was related to carotid IMT and plaque occurrence in the 
carotid arteries.  
It has been hypothesized that LDL is oxidized in the intima of the arterial vessel wall. 
Oxidized LDL increases the adherence and penetration of monocytes, by stimulating 
monocyte chemoattractant protein-1 (MCP-1) and the inflammatory process, resulting in foam 
cell formation and thereby triggering the atherosclerotic lesion (11). Oxidized LDL is found 
in monocyte-derived macrophages in atherosclerotic lesion, but not in normal arteries (1). It 
has also been suggested that ox-LDL induces smooth muscle cell proliferation (7). 
Our study also supports an earlier prospective study, which showed that baseline ox-
LDL was associated with number of plaques in the carotid artery (12). Furthermore, ox-LDL 
has been shown to be directly related to the severity of the disease, assessed by angiography 
(9). In the study by Hulthe and Fagerberg 2002, ox-LDL showed a good correlation with 
cytokines, indicating its role in triggering the immune system. Furthermore, earlier studies 
provided evidence for the role of ox-LDL in triggering adhesion of monocytes favoring the 
progression of atherosclerotic process (10). 
Previous studies of patients with acute coronary syndromes have suggested that 
elevated serum levels of ox-LDL could be explained by ruptured atherosclerotic plaques, 
ischemic injury, or even remote inflammatory sources (13). 
            The results of the present study are also in accordance with the study of Hulthe, 
Fagerberg and Metso who showed that ox-LDL showed a strong association with IMT (12). 
To conclude, the finding that circulating oxidized LDL is associated with the severity 
of coronary atherosclerosis supports the hypothesis that oxidized LDL has a profound role in 
the development of atherosclerosis. 
Intima–media thickness of the internal carotid artery is strongly associated with the 
risk of myocardial infarction and stroke in hypertensive patients. Measurements of carotid-
artery intima–media thickness retain predictive power with respect to new cardiovascular 
events even after traditional risk factors for cardiovascular events have been taken into 
consideration; moreover, such measurements seem more powerful predictors than these same 
risk factors.  
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